259 related articles for article (PubMed ID: 31345180)
21. Outcome of 12-month surveillance colonoscopy in high-risk patients in the National Health Service Bowel Cancer Screening Programme.
Lee TJ; Nickerson C; Goddard AF; Rees CJ; McNally RJ; Rutter MD
Colorectal Dis; 2013 Aug; 15(8):e435-42. PubMed ID: 23663559
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of distal colonic polyps for prediction of advanced proximal neoplasia in an average-risk population undergoing screening colonoscopy.
Betés Ibáñez M; Muñoz-Navas MA; Duque JM; Angós R; Macías E; Súbtil JC; Herraiz M; de la Riva S; Delgado-Rodríguez M; Martínez-Gonzélez MA
Gastrointest Endosc; 2004 May; 59(6):634-41. PubMed ID: 15114305
[TBL] [Abstract][Full Text] [Related]
23. Computed tomographic colonography for colorectal cancer screening: risk factors for the detection of advanced neoplasia.
Hassan C; Pooler BD; Kim DH; Rinaldi A; Repici A; Pickhardt PJ
Cancer; 2013 Jul; 119(14):2549-54. PubMed ID: 23754679
[TBL] [Abstract][Full Text] [Related]
24. The mean number of adenomas per procedure should become the gold standard to measure the neoplasia yield of colonoscopy: a population-based cohort study.
Denis B; Sauleau EA; Gendre I; Exbrayat C; Piette C; Dancourt V; Foll Y; Ait Hadad H; Bailly L; Perrin P
Dig Liver Dis; 2014 Feb; 46(2):176-81. PubMed ID: 24054769
[TBL] [Abstract][Full Text] [Related]
25. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Levillain R; Tichet J; Launoy G
Int J Cancer; 2009 Sep; 125(5):1127-33. PubMed ID: 19431212
[TBL] [Abstract][Full Text] [Related]
26. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
Cubiella J; Digby J; Rodríguez-Alonso L; Vega P; Salve M; Díaz-Ondina M; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Rodriguez-Moranta F; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Garayoa A; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Steele RJ; Fraser CG;
Int J Cancer; 2017 May; 140(10):2201-2211. PubMed ID: 28187494
[TBL] [Abstract][Full Text] [Related]
27. Adenoma Detection Rate in Asymptomatic Patients with Positive Fecal Immunochemical Tests.
Kligman E; Li W; Eckert GJ; Kahi C
Dig Dis Sci; 2018 May; 63(5):1167-1172. PubMed ID: 29468377
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening.
Tao S; Hoffmeister M; Brenner H
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):478-85. PubMed ID: 24022090
[TBL] [Abstract][Full Text] [Related]
29. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
[TBL] [Abstract][Full Text] [Related]
30. Diminutive Polyps With Advanced Histologic Features Do Not Increase Risk for Metachronous Advanced Colon Neoplasia.
Vleugels JLA; Hassan C; Senore C; Cassoni P; Baron JA; Rex DK; Ponugoti PL; Pellise M; Parejo S; Bessa X; Arnau-Collell C; Kaminski MF; Bugajski M; Wieszczy P; Kuipers EJ; Melson J; Ma KH; Holman R; Dekker E; Pohl H
Gastroenterology; 2019 Feb; 156(3):623-634.e3. PubMed ID: 30395813
[TBL] [Abstract][Full Text] [Related]
31. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients.
Cubiella J; Vega P; Salve M; Díaz-Ondina M; Alves MT; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Clofent J; Ferrandez Á; Torrealba L; Piñol V; Rodríguez-Alcalde D; Hernández V; Fernández-Seara J;
BMC Med; 2016 Aug; 14(1):128. PubMed ID: 27580745
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
[TBL] [Abstract][Full Text] [Related]
33. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer.
Imperiale TF; Wagner DR; Lin CY; Larkin GN; Rogge JD; Ransohoff DF
Ann Intern Med; 2003 Dec; 139(12):959-65. PubMed ID: 14678915
[TBL] [Abstract][Full Text] [Related]
34. Five-year colon surveillance after screening colonoscopy.
Lieberman DA; Weiss DG; Harford WV; Ahnen DJ; Provenzale D; Sontag SJ; Schnell TG; Chejfec G; Campbell DR; Kidao J; Bond JH; Nelson DB; Triadafilopoulos G; Ramirez FC; Collins JF; Johnston TK; McQuaid KR; Garewal H; Sampliner RE; Esquivel R; Robertson D
Gastroenterology; 2007 Oct; 133(4):1077-85. PubMed ID: 17698067
[TBL] [Abstract][Full Text] [Related]
35. Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test.
Pin-Vieito N; Iglesias MJ; Remedios D; Rodríguez-Alonso L; Rodriguez-Moranta F; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Martínez-Bauer E; Campo R; Bujanda L; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Cubiella J; On Behalf Of The Colonpredict Study Investigators
World J Gastroenterol; 2020 Jan; 26(1):70-85. PubMed ID: 31933515
[TBL] [Abstract][Full Text] [Related]
36. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
[TBL] [Abstract][Full Text] [Related]
37. Fecal immunochemical testing results and characteristics of colonic lesions.
van Doorn SC; Stegeman I; Stroobants AK; Mundt MW; de Wijkerslooth TR; Fockens P; Kuipers EJ; Bossuyt PM; Dekker E
Endoscopy; 2015 Nov; 47(11):1011-7. PubMed ID: 26126163
[TBL] [Abstract][Full Text] [Related]
38. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
39. Low Sensitivity of Fecal Immunochemical Tests and Blood-Based Markers of DNA Hypermethylation for Detection of Sessile Serrated Adenomas/Polyps.
Cock C; Anwar S; Byrne SE; Meng R; Pedersen S; Fraser RJL; Young GP; Symonds EL
Dig Dis Sci; 2019 Sep; 64(9):2555-2562. PubMed ID: 30835026
[TBL] [Abstract][Full Text] [Related]
40. Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening.
Yuan SY; Wu W; Fu J; Lang YX; Li JC; Guo Y; Wang YN; Qian JM; Li JN
J Dig Dis; 2019 Feb; 20(2):78-82. PubMed ID: 30714346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
